[Form 4] Ovintiv Inc. Insider Trading Activity

Rhea-AI Filing Summary

Brendan Michael McCracken, President & CEO and Director of Ovintiv Inc. (OVV), received 1,577 restricted share units (RSUs) on 09/29/2025 as dividend-equivalent RSUs at a $0 price. The filing shows these RSUs are economically equivalent to one share each and will vest and settle per the Omnibus Incentive Plan and the applicable grant agreement, subject to continued employment. After this grant, the reporting person beneficially owns 228,521 shares of common stock. The transaction was reported on Form 4 and executed under the company’s compensation arrangements for executives.

Positive

• Alignment of interests: RSUs convert dividend equivalents into equity, aligning the CEO’s compensation with shareholder outcomes.
• Clear disclosure: Form 4 reports the grant amount, nature of the award, and post-transaction beneficial ownership of 228,521 shares.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine executive dividend-equivalent RSU award that aligns CEO incentives with shareholders without immediate cash payout.

This Form 4 reports an award of 1,577 RSUs granted as dividend equivalents and recorded at $0 price, consistent with compensation practices that convert cash dividends into equity-like awards. The disclosure notes vesting and settlement follow the Omnibus Incentive Plan and the grant agreement and are conditioned on continued employment. The filing is a standard Section 16 disclosure showing insider beneficial ownership increased to 228,521 shares.

Securities Analyst

TL;DR: Non-cash RSU issuance reported; impact on share count and executive alignment is minimal and routine per the filing.

The transaction is coded as an acquisition (A) of 1,577 Restricted Share Units received as dividend equivalents for Q3 2025. The RSUs are described as economically equivalent to common shares and include dividend equivalents. The filing provides clear post-transaction beneficial ownership of 228,521 shares for the reporting person. This is a routine disclosure without additional financial metrics or pricing implications in the form.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

McCracken Brendan Michael

(Last) (First) (Middle)

C/O 370 17TH STREET, SUITE 1700

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ovintiv Inc. [ OVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Unit	(1)	09/29/2025		A		1,577		(1)	(1)	Common Stock	1,577	$0(2)	228,521	D

Explanation of Responses:

1. Each Restricted Share Unit ("RSU'') is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs, subject to the grantee's continued employment with Ovintiv through the applicable exercise date.

2. Dividend equivalent RSUs received in lieu of cash dividends for the third quarter of 2025.

	/s/ Dawna Gibb, by Power of Attorney	09/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed this Form 4 for Ovintiv (OVV)?

The filing was made on behalf of Brendan Michael McCracken, identified as President & CEO and a Director.

What transaction is reported on the Form 4 for OVV?

The report shows acquisition of 1,577 Restricted Share Units (RSUs) received as dividend equivalents on 09/29/2025.

What price was paid for the RSUs reported in the Form 4?

The dividend-equivalent RSUs are reported at a $0 price in the filing.

How many Ovintiv shares does the reporting person beneficially own after the transaction?

After the reported transaction, the reporting person beneficially owns 228,521 shares of common stock.

Do the RSUs vest immediately according to the Form 4?

No; the Form 4 states vesting and settlement will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement, subject to continued employment.